Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin
about
Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs.Targeting β-catenin in hepatocellular cancers induced by coexpression of mutant β-catenin and K-Ras in mice.β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.WNTing no RASt for hepatocellular carcinoma.A Dominant Negative Antisense Approach Targeting β-Catenin.
P2860
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Direct Pharmacological Inhibit ...... ce in Tumors of Diverse Origin
@en
Direct Pharmacological Inhibit ...... e in Tumors of Diverse Origin.
@nl
type
label
Direct Pharmacological Inhibit ...... ce in Tumors of Diverse Origin
@en
Direct Pharmacological Inhibit ...... e in Tumors of Diverse Origin.
@nl
prefLabel
Direct Pharmacological Inhibit ...... ce in Tumors of Diverse Origin
@en
Direct Pharmacological Inhibit ...... e in Tumors of Diverse Origin.
@nl
P2093
P2860
P1476
Direct Pharmacological Inhibit ...... ce in Tumors of Diverse Origin
@en
P2093
Bob D Brown
Chengjung Lai
Dongyu Chen
Edmond Chipumuro
Girish R Chopda
Henryk Dudek
Junyan Tao
Kevin Craig
Marc T Abrams
P2860
P304
P356
10.1158/1535-7163.MCT-16-0309
P577
2016-07-07T00:00:00Z